BR9507080A - Métodos para tornar compostos orgânicos solúveis em sistemas graxos novos complexos químicos de tais compostos e várias aplicações dos complexos - Google Patents

Métodos para tornar compostos orgânicos solúveis em sistemas graxos novos complexos químicos de tais compostos e várias aplicações dos complexos

Info

Publication number
BR9507080A
BR9507080A BR9507080A BR9507080A BR9507080A BR 9507080 A BR9507080 A BR 9507080A BR 9507080 A BR9507080 A BR 9507080A BR 9507080 A BR9507080 A BR 9507080A BR 9507080 A BR9507080 A BR 9507080A
Authority
BR
Brazil
Prior art keywords
complexes
fatty acid
pct
carbon atoms
acid moiety
Prior art date
Application number
BR9507080A
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Morten Sloth Weidner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8091955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507080(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morten Sloth Weidner filed Critical Morten Sloth Weidner
Publication of BR9507080A publication Critical patent/BR9507080A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
BR9507080A 1994-03-14 1995-03-14 Métodos para tornar compostos orgânicos solúveis em sistemas graxos novos complexos químicos de tais compostos e várias aplicações dos complexos BR9507080A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK29694 1994-03-14
PCT/DK1995/000118 WO1995025084A1 (en) 1994-03-14 1995-03-14 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes

Publications (1)

Publication Number Publication Date
BR9507080A true BR9507080A (pt) 1997-09-16

Family

ID=8091955

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507080A BR9507080A (pt) 1994-03-14 1995-03-14 Métodos para tornar compostos orgânicos solúveis em sistemas graxos novos complexos químicos de tais compostos e várias aplicações dos complexos

Country Status (13)

Country Link
US (1) US6087391A (pt)
EP (1) EP0750604B1 (pt)
JP (1) JP3802927B2 (pt)
CN (1) CN1114589C (pt)
AT (1) ATE161527T1 (pt)
AU (1) AU680355B2 (pt)
BR (1) BR9507080A (pt)
DE (1) DE69501325T2 (pt)
ES (1) ES2113738T3 (pt)
GR (1) GR3026479T3 (pt)
HU (1) HU222373B1 (pt)
RU (1) RU2145320C1 (pt)
WO (1) WO1995025084A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767062B1 (fr) * 1997-08-11 2000-03-17 Andre Pierre Morice Composition comprenant de la propolis
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
AU2003240441B2 (en) * 2002-06-20 2008-09-18 Cipher Pharmaceuticals, Inc. Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
US20040195549A1 (en) 2003-04-04 2004-10-07 Clifford Adams Lipid-soluble formulations containing mixtures of antioxidants
DK2192160T3 (en) * 2008-12-01 2016-12-12 Aquanova Ag INTEGRATED oxidation of micelles FOR NATURAL DYES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
EP0543943B1 (en) * 1990-08-13 1995-04-26 YESAIR, David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
DE69119605D1 (de) * 1990-11-12 1996-06-20 Fileco Sa Antivirale verwendung einer in position-4 substituierten 2,6-di-t-butylphenolverbindung, besonders gegen herpes- und papillomaviren

Also Published As

Publication number Publication date
ATE161527T1 (de) 1998-01-15
AU1945995A (en) 1995-10-03
HU222373B1 (hu) 2003-06-28
DE69501325D1 (de) 1998-02-05
EP0750604B1 (en) 1997-12-29
JP3802927B2 (ja) 2006-08-02
RU2145320C1 (ru) 2000-02-10
AU680355B2 (en) 1997-07-24
GR3026479T3 (en) 1998-06-30
WO1995025084A1 (en) 1995-09-21
US6087391A (en) 2000-07-11
DE69501325T2 (de) 1998-09-03
JPH09510224A (ja) 1997-10-14
CN1114589C (zh) 2003-07-16
ES2113738T3 (es) 1998-05-01
HUT76420A (en) 1997-08-28
EP0750604A1 (en) 1997-01-02
CN1143949A (zh) 1997-02-26
HU9602513D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
EP1961312A3 (en) Microbial oil mixture and uses thereof
AU3706493A (en) Nutritional comosition containing a low ph form of an amino acid
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
GEP19991704B (en) Carbon Derivatives, Method for Its Production, Compositions Based Thereon
CA2054955A1 (fr) Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion de vesicules lipidiques
MX173582B (es) Espesante de arcilla para emplear en sistemas basados en agua y compuestos de union que contienen esas composiciones
BR9507080A (pt) Métodos para tornar compostos orgânicos solúveis em sistemas graxos novos complexos químicos de tais compostos e várias aplicações dos complexos
EP0344880A3 (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer
AU1972188A (en) Lipid emulsion intended for parenteral or enteral feeding
AU652785B2 (en) Nutrition
NZ325259A (en) Phospholipid derivatives of phosphono-carboxylic acids, the production of said derivatives and the use of said derivatives as antiviral medicaments
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
TW364905B (en) Lactone compound and process of production thereof
WO1996004886A3 (en) Gelling compositions comprising optically enriched gellants
MY110206A (en) Substituted mandelic acid derivaties,processes for their preparation and their use in medicaments
KR890003793A (ko) 3'-데메톡시에피포도필로톡신 배당체의 유도체
EP0212287A3 (en) Process for producing aliphatic diamine dimers
GB2321459A (en) Synthesis of carboxylic acid derivatives
AU7343287A (en) Process of preparation of new catalysts containing rhodium and their application
SU1637326A1 (ru) Питательная среда для выращивания холерного вибриона
JPS57206691A (en) 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-yl phosphoric ester
IL89909A (en) Thermal oxidatively stable synthetic fluid composition
TH14595A (th) เกลือเซฟาโลสพอริน และกรรมวิธีสำหรับเตรียมสารนั้น
MX9603891A (es) Compuestos de 9-desoxotaxano.
MY105876A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer.

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B25G Requested change of headquarter approved
B25A Requested transfer of rights approved

Free format text: EUROVITA A/S (DK)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/09/2005, OBSERVADAS AS CONDICOES LEGAIS. AS REIVINDICACOES NO 1 A 10 E 12, SERAO ACEITAS COM RESSALVA DO QUE INCIDIR NOS ART. 229 E ART. 229-A DA LEI 10196, DE 14 DE FEVEREIRO DE 2001.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-524000.061598/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132260-18.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: D. WESTERN THERAPEUTICS INSTITUTE, KOWA COMPANY, LTD., DURECT CORPORATION, ELANCO ANIMAL HEALTH IRELAND LIMITED, EUROVITA A/S, EVONIK GOLDSCHMIDT GMBH

B21B Extinction acc. art. 78, item ii - on waiver by the patentee, without prejudice to the rights of third parties

Free format text: SOLICITADA ATRAVES DA PETICAO 860130008424, DE 27/11/2013

B15K Others concerning applications: alteration of classification

Ipc: A61K 47/54 (2017.01)